Source - RNS
RNS Number : 8317J
Source BioScience PLC
14 September 2016
 

 

14 September 2016

 

Source BioScience plc
(or "the Company")

PDMR dealings

 

This announcement is made in accordance with Article 19.3 of MAR and Rule 8 of the City Code on Takeovers and Mergers following the exercise of share options granted under the Company's Share Option Schemes on behalf of PDMRs.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mr Laurie Turnbull

b)

Position/status

PDMR, Chairman

c)

Initial notification /Amendment

Initial Notification

2

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Source BioScience plc

3

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 2p each ("Ordinary Shares")



ISIN Code: GB0009739649

b)

Nature of the transaction

Exercise of share options

c)

Price(s) and volume(s)

Price:  Nil

Volume: 298,667

d)

 

Aggregated information

- Aggregated volume

- Price

N/A

 

 

e)

Date of the transaction

13 September 2016

f)

Place of the transaction

Outside a trading venue

4

Resultant holding in Ordinary Shares

3,048,667 (0.8%)

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Dr Nick Ash

b)

Position/status

PDMR, CEO

c)

Initial notification /Amendment

Initial Notification

2

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Source BioScience plc

3

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 2p each ("Ordinary Shares")



ISIN Code: GB0009739649

b)

Nature of the transaction

Exercise of share options

c)

Price(s) and volume(s)

Price:  Nil

Volume:  3,474,965

d)

Aggregated information

- Aggregated volume

- Price

N/A

 

 

e)

Date of the transaction

13 September 2016

f)

Place of the transaction

Outside a trading venue

4

Resultant holding in Ordinary Shares

3,974,965 (1.1%)

 

1

Details of the person discharging managerial responsibilities / person closely associated 

a)

Name

Dr Nick Leaves

b)

Position/status

PDMR, Chief Operating Officer

c)

Initial notification /Amendment

Initial Notification

2

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Source BioScience plc

3

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 2p each ("Ordinary Shares")



ISIN Code: GB0009739649

b)

Nature of the transaction

Exercise of share options

c)

Price(s) and volume(s)

Price:  Nil

Volume:  2,867,456

d)

Aggregated information

- Aggregated volume

- Price

N/A

 

 

e)

Date of the transaction

13 September 2016

f)

Place of the transaction

Outside a trading venue

4

Resultant holding in Ordinary Shares

3,896,013 (1.1%)

  

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mr Tim Metcalfe

b)

Position/status

PDMR, Group Finance Director

c)

Initial notification /Amendment

Initial Notification

2

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Source BioScience plc

3

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 2p each ("Ordinary Shares")



ISIN Code: GB0009739649

b)

Nature of the transaction

Exercise of share options

c)

Price(s) and volume(s)

Price:  Nil

Volume:  1,606,154

d)

Aggregated information

- Aggregated volume

- Price

N/A

 

 

e)

Date of the transaction

13 September 2016

f)

Place of the transaction

Outside a trading venue

4

Resultant holding in Ordinary Shares

1,606,154 (0.4%)

 

Enquiries

Source BioScience plc
Dr Nick Ash, Company Secretary
Tel: +44 (0) 115 973 9010
Email:
[email protected]
www.sourcebioscience.com
 

 

About Source BioScience:

Source BioScience plc (LSE: SBS) is a trusted provider of state of the art Laboratory Services and Products to the healthcare and clinical, life and applied sciences and biopharma industries.  It is an international business operating ten state of the art facilities in five countries and with customers in over 90 countries worldwide.  The Group offers a complementary portfolio of Laboratory Services and Products that share common technologies, laboratory processes, infrastructure and expertise. These include Diagnostics, DNA Sequencing and Genomics, Analytical and Regulated Services, Clinical Products, Life Science Research Reagents and Controlled Environment for a comprehensive range of applications.  These Laboratory Services and Products are provided to a large and diverse customer base including the top 50 pharmaceutical companies, leading universities and research institutes worldwide, the UK NHS and other healthcare providers.  The Group is listed on the Premium Main Market of the London Stock Exchange.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHSFAFSLFMSEEU